Lipitor / Torcetrapib - Combination Therapy for the Management of Dyslipidaemia
Key Data:
Drug (brand/generic)
Lipitor / Torcetrapib
Company/licensee
Pfizer
Therapy class
Combination anti-dyslipidaemic agent
Product description
Single agent statin and CETP inhibitor combination therapy
Current indication
Treatment of dyslipidaemia
Market sector
CVD
Development status
Discontinued
